Tenax Therapeutics (TENX) Depreciation & Amortization (CF) (2010 - 2023)
Tenax Therapeutics recorded quarterly Depreciation & Amortization (CF) of $5136.0 in Q4 2023, up 430.03% quarter-over-quarter from $969.0 in Q3 2023, and up 281.86% year-over-year from $1345.0 in Q4 2022.
Tenax Therapeutics' Depreciation & Amortization (CF) history runs 14 years deep, the most recent figure standing at $5136.0 for Q4 2023.
- In Q4 2023, Depreciation & Amortization (CF) rose 281.86% year-over-year to $5136.0; the TTM figure through Sep 2024 stood at $5136.0 (up 22.02% YoY), while the FY2023 annual figure was $8000.0, up 55.55% from the prior year.
- Depreciation & Amortization (CF) came in at $5136.0 for Q4 2023 at Tenax Therapeutics, up from $969.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $5136.0 in Q4 2023 to a low of $891.0 in Q2 2021.
- A 5-year average of $1317.6 and a median of $1113.5 in 2019 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) plunged 56.74% in 2019 and jumped 281.86% in 2023, its largest moves.
- Tenax Therapeutics' Depreciation & Amortization (CF) stood at $1308.0 in 2019, then decreased by 25.15% to $979.0 in 2020, then climbed by 10.21% to $1079.0 in 2021, then climbed by 24.65% to $1345.0 in 2022, then surged by 281.86% to $5136.0 in 2023.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $5136.0, $969.0, and $1000.0 for Q4 2023, Q3 2023, and Q2 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 123.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 5,136.00 |
| Dec 31, 2023 | 5,136.00 |
| Sep 30, 2023 | 969.00 |
| Sep 30, 2023 | 969.00 |
| Jun 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 895.00 |
| Mar 31, 2023 | 895.00 |
| Dec 31, 2022 | 1,345.00 |
| Dec 31, 2022 | 1,345.00 |
| Sep 30, 2022 | 1,210.00 |
| Sep 30, 2022 | 1,210.00 |
| Jun 30, 2022 | 1,235.00 |
| Jun 30, 2022 | 1,235.00 |
| Mar 31, 2022 | 1,353.00 |
| Mar 31, 2022 | 1,353.00 |
| Dec 31, 2021 | 1,079.00 |
| Dec 31, 2021 | 1,079.00 |
| Sep 30, 2021 | 1,011.00 |
| Sep 30, 2021 | 1,011.00 |
| Jun 30, 2021 | 891.00 |
| Jun 30, 2021 | 891.00 |
| Mar 31, 2021 | 1,135.00 |
| Mar 31, 2021 | 1,135.00 |
| Dec 31, 2020 | 979.00 |
| Dec 31, 2020 | 979.00 |
| Sep 30, 2020 | 948.00 |
| Sep 30, 2020 | 948.00 |
| Jun 30, 2020 | 1,037.00 |
| Jun 30, 2020 | 1,037.00 |
| Mar 31, 2020 | 1,113.00 |
| Mar 31, 2020 | 1,113.00 |
| Dec 31, 2019 | 1,308.00 |
| Dec 31, 2019 | 1,308.00 |
| Sep 30, 2019 | 1,309.00 |
| Sep 30, 2019 | 1,309.00 |
| Jun 30, 2019 | 1,286.00 |
| Jun 30, 2019 | 1,286.00 |
| Mar 31, 2019 | 1,114.00 |
| Mar 31, 2019 | 1,114.00 |
| Dec 31, 2018 | 1,442.00 |
| Dec 31, 2018 | 1,442.00 |
| Sep 30, 2018 | 2,132.00 |
| Sep 30, 2018 | 2,132.00 |
| Jun 30, 2018 | 2,867.00 |
| Jun 30, 2018 | 2,867.00 |
| Mar 31, 2018 | 2,575.00 |
| Mar 31, 2018 | 2,575.00 |
| Dec 31, 2017 | 3,022.00 |
| Dec 31, 2017 | 3,022.00 |
| Sep 30, 2017 | 3,143.00 |
| Sep 30, 2017 | 3,143.00 |
| Jun 30, 2017 | 3,424.00 |
| Jun 30, 2017 | 3,424.00 |
| Mar 31, 2017 | 4,032.00 |
| Mar 31, 2017 | 4,032.00 |
| Dec 31, 2016 | 4,421.00 |
| Dec 31, 2016 | 4,421.00 |
| Sep 30, 2016 | 4,820.00 |
| Sep 30, 2016 | 4,820.00 |
| Jun 30, 2016 | 5,073.00 |
| Jun 30, 2016 | 5,073.00 |
| Mar 31, 2016 | 4,638.00 |
| Mar 31, 2016 | 4,638.00 |
| Dec 31, 2015 | 31,224.00 |
| Dec 31, 2015 | 31,224.00 |
| Sep 30, 2015 | 12,475.00 |
| Sep 30, 2015 | 12,475.00 |
| Jun 30, 2015 | 23,500.00 |
| Jun 30, 2015 | 23,500.00 |
| Jan 31, 2015 | 18,000.00 |
| Jan 31, 2015 | 18,000.00 |
| Oct 31, 2014 | 21,000.00 |
| Oct 31, 2014 | 21,000.00 |
| Jul 31, 2014 | 38,486.00 |
| Jul 31, 2014 | 38,486.00 |
| Apr 30, 2014 | 39,257.00 |
| Apr 30, 2014 | 39,257.00 |
| Jan 31, 2014 | 36,299.00 |
| Jan 31, 2014 | 36,299.00 |
| Oct 31, 2013 | 37,633.00 |
| Oct 31, 2013 | 37,633.00 |
| Jul 31, 2013 | 37,300.00 |
| Jul 31, 2013 | 37,300.00 |
| Apr 30, 2013 | 38,060.00 |
| Apr 30, 2013 | 38,060.00 |
| Jan 31, 2013 | 36,972.00 |
| Jan 31, 2013 | 36,972.00 |
| Oct 31, 2012 | 36,681.00 |
| Oct 31, 2012 | 36,681.00 |
| Jul 31, 2012 | 37,091.00 |
| Jul 31, 2012 | 37,091.00 |
| Apr 30, 2012 | 40,543.00 |
| Apr 30, 2012 | 40,543.00 |
| Jan 31, 2012 | 47,270.00 |
| Jan 31, 2012 | 47,270.00 |
| Oct 31, 2011 | 27,792.00 |
| Oct 31, 2011 | 27,792.00 |
| Jul 31, 2011 | 91,072.00 |
| Jul 31, 2011 | 91,072.00 |
| Apr 30, 2011 | 55,969.00 |
| Apr 30, 2011 | 55,969.00 |
| Jan 31, 2011 | 64,319.00 |
| Jan 31, 2011 | 64,319.00 |
| Oct 31, 2010 | 57,501.00 |
| Oct 31, 2010 | 57,501.00 |
| Jul 31, 2010 | 133,237.00 |
| Jul 31, 2010 | 133,237.00 |